Q3 2024 · 13F-HR/A
Birchview Capital, LPholdings as filed
Filed 2025-06-30 · accession 0001618205-25-000007
$115.5M
Reported value
61
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $35.5M | 30.7% | 686,182 | Common | SOLE |
| 09075X108 | — | BIODESIX INC COM RST | $10.1M | 8.76% | 5,696,113 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $6.2M | 5.33% | 400,400 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $5.0M | 4.36% | 1,321,215 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $3.6M | 3.10% | 10,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $3.5M | 3.04% | 209,574 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $3.5M | 3.02% | 30,240 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $3.4M | 2.97% | 74,000 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $3.3M | 2.84% | 72,910 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $3.1M | 2.67% | 67,619 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $3.0M | 2.59% | 320,930 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $2.8M | 2.39% | 197,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $2.6M | 2.26% | 114,700 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.6M | 2.23% | 210,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.2M | 1.87% | 48,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.1M | 1.79% | 148,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $2.0M | 1.76% | 15,280 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $2.0M | 1.73% | 52,200 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $1.7M | 1.48% | 515,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $1.7M | 1.43% | 58,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 1.21% | 50,000 | Common | SOLE |
| 26884L109 | EQT | EQT CORPORATION | $1.3M | 1.10% | 34,619 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $1.1M | 0.95% | 198,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $949,560 | 0.82% | 82,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $749,700 | 0.65% | 30,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $677,400 | 0.59% | 30,000 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $572,400 | 0.50% | 10,000 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $556,158 | 0.48% | 325,239 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $528,000 | 0.46% | 10,000 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $502,843 | 0.44% | 32,110 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $406,490 | 0.35% | 7,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $403,760 | 0.35% | 14,000 | Common | SOLE |
| 89455T109 | TMCI | TREACE MEDICAL CONCEPTS INC | $396,430 | 0.34% | 68,350 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $393,700 | 0.34% | 10,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $389,961 | 0.34% | 469,832 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $386,880 | 0.33% | 372,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $369,450 | 0.32% | 15,000 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $368,720 | 0.32% | 22,000 | Common | SOLE |
| G11196105 | — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $368,029 | 0.32% | 7,365 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $359,480 | 0.31% | 4,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $334,800 | 0.29% | 20,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $328,000 | 0.28% | 40,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $320,400 | 0.28% | 10,000 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $312,600 | 0.27% | 20,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $312,225 | 0.27% | 2,500 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $304,000 | 0.26% | 40,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $299,040 | 0.26% | 28,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $249,750 | 0.22% | 2,700 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $247,353 | 0.21% | 12,300 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $136,297 | 0.12% | 138,176 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $109,718 | 0.10% | 211,200 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $106,800 | 0.09% | 10,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $100,000 | 0.09% | 10,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $98,600 | 0.09% | 20,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $76,500 | 0.07% | 50,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $74,732 | 0.06% | 15,833 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $62,784 | 0.05% | 28,800 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $58,880 | 0.05% | 16,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $47,200 | 0.04% | 10,000 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MEDICAL INC | $6,770 | 0.01% | 10,000 | Common | SOLE |
| 71902K105 | — | CERO THERAPEUTICS HOLDINGS INC | $1,210 | 0.00% | 12,972 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.